Finzati - Logo
ETON logo

Eton Pharmaceuticals, Inc.

ETON • Drug Manufacturers - Specialty & Generic
$58.45
▼ -1.45 (-2.42%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.84B
Growth
—
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 36.1%Positive free cash flow · 0.38Consistent free cash flow · 4/5Healthy liquidity · 1.57Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$58.45
Change-2.42%
Shares Out31.55M
Market Cap$1.84B
Enterprise Value$1.84B
52W Range13.09 - 35.66
Beta1.01
P/E-1,250.12
P/S21.21
P/B60.23
P/FCF4,278.24
EV/Sales21.13

Investment DNA

How strong this company looks for long-term investors

51
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
29/100
Why this score▼
Positive revenue growth · 36.1%Positive free cash flow · 0.38Consistent free cash flow · 4/5Healthy liquidity · 1.57Weak profitability

Analyst view

Analyst sentiment and price target

ETON
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
100/100
Bullish
Bullish
7
Hold
0
Bearish
0
Price Target
2026-06-24
Low
$57.00
Mean
$57.00
Median
$57.00
High
$57.00

Company Overview

IPO: 11/14/2018
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 60.23
Debt / Equity i: 1.19
Operating Margin: 0.09%
Net Margin: -5.75%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 1.19
Current Ratio: 1.57
Quick Ratio: 1.17
Status: Good

Insider Transactions

Recent executive and insider activity

Adams Jennifer McKie
Transaction: 06/17/2026
SELL
Change
-50,000
Price
$3.78
Filing
06/17/2026
Type
SELL
Adams Jennifer McKie
Transaction: 06/17/2026
SELL
Change
-50,000
Price
$32.48
Filing
06/17/2026
Type
SELL
Matthews Judith M.
Transaction: 06/01/2026
OTHER
Change
+37,000
Price
$26.05
Filing
06/01/2026
Type
OTHER